scholarly journals Effect of Flat Cornea on Visual Outcome after LASIK

2015 ◽  
Vol 2015 ◽  
pp. 1-7 ◽  
Author(s):  
Engy Mohamed Mostafa
Keyword(s):  
Visual Acuity ◽  
High Myopia ◽  
Visual Outcome ◽  
Laser In Situ Keratomileusis ◽  
Refractive Outcome ◽  
Corrected Distance Visual Acuity ◽  
Group 3 ◽  
Group 2 ◽  
Group 1

Purpose. To evaluate the effect of preoperative and postoperative keratometry on the refractive outcome after laser in situ keratomileusis (LASIK) for moderate and high myopia.Methods. Records of 812 eyes (420 patients) with myopia ≥−6 D who had LASIK at Sohag Laser Center, Egypt, from January 2010 to November 2013, were retrospectively analyzed. Main outcome measures were postoperative corrected distance visual acuity (CDVA), postoperative spherical equivalence, and postoperativeQfactor.Results. LASIK was performed in 812 eyes (mean age21.8±5.2years). Patients were grouped according to the degree of preoperative myopia into three groups: Group 1, −6 D to −7.9 D; Group 2, −8 to −9.9 D; and Group 3, −10 to −12 D. The refractive outcome among the different myopia groups was stratified by pre- and postoperative keratometry. A trend toward greater undercorrection was noted in eyes with preoperative keratometry <43.5 D compared with those with steeper keratometry >46 D in all myopia groups. The undercorrection was also noted in postoperative keratometry groups <35 D.Conclusions. Preoperative and postoperative keratometry appeared to influence the refractive outcome especially in high myopic eyes.

scholarly journals Effect of Cap-Lenticule Diameter Difference on the Visual Outcome and Higher-Order Aberrations in SMILE: 0.4 mm versus 1.0 mm

2017 ◽  
Vol 2017 ◽  
pp. 1-7
Author(s):  
Banu Torun Acar ◽  
Suphi Acar
Keyword(s):  
Visual Acuity ◽  
Visual Outcome ◽  
Higher Order ◽  
Early Postoperative Period ◽  
Higher Order Aberrations ◽  
Corrected Distance Visual Acuity ◽  
Lenticule Extraction ◽  
Group 2 ◽  
Group 1

Purpose. To evaluate the effect of cap-lenticule diameter difference (CLDD) on the visual outcome and higher-order aberrations (HOAs) of small-incision lenticule extraction (SMILE). Methods. A total of 132 patients who had bilateral SMILE for myopia or myopic astigmatism were included. The CLDD was 0.4 mm in 54 patients (group 1) and 1.0 mm in 78 patients (group 2). The refractive parameters, uncorrected (UDVA) and corrected distance visual acuity (CDVA), and HOAs were determined preoperatively and during six months follow-up. Results. Group 1 had better CDVA (in logMAR) compared to group 2 at day 1 (−0.07 ± 0.07 versus 0.04 ± 0.07, resp.; p<0.001) and week 1 (−0.07 ± 0.07 versus –0.04 ± 0.07, resp.; p=0.001). The visual acuity improved more in group 1 than in group 2. The UDVA (in logMAR) was 0.07 ± 0.07 and 0.29 ± 0.09 at day 1 (p<0.001) and −0.08 ± 0.07 and −0.06 ± 0.06 at six months (p=0.038) in group 1 and group 2, respectively. Group 1 was associated with significantly less induction of HOAs (0.24 ± 0.08 μm and 0.32 ± 0.26 μm, resp.; p=0.002). Conclusions. In SMILE, 0.4 mm CLDD is associated with better visual outcome and less induction of HOAs than 1.0 mm. Narrow CLDD should be considered in SMILE to increase the visual acuity particularly in the early postoperative period.

scholarly journals Clinical Outcomes of Single-Step Transepithelial Photorefractive Keratectomy and Off-Flap Epipolis-Laser in Situ Keratomileusis in Moderate to High Myopia: 12-Month Follow-Up

2021 ◽  
Author(s):  
Yunjie Zhang ◽  
Tiankun Li ◽  
Zhangliang Li ◽  
Mali Dai ◽  
Qinmei Wang ◽  
...  
Keyword(s):  
Visual Acuity ◽  
Contrast Sensitivity ◽  
High Myopia ◽  
Single Step ◽  
Self Control ◽  
Laser In Situ Keratomileusis ◽  
Photorefractive Keratectomy ◽  
Group 3

Abstract Background To compare the quantitative and qualitative optical outcomes of single-step transepithelial photorefractive keratectomy (TPRK) and off-flap epipolis-laser in situ keratomileusis (Epi-LASIK) in moderate to high myopia. Methods In this prospective self-control study, we included patients with moderate to high myopia who were randomized to undergo TPRK in one eye and Epi-LASIK in the other eye. Twelve-month follow-up results for visual acuity, refraction, ocular high-order aberrations, contrast sensitivity, postoperative pain, epithelial healing, and haze grade were assessed. Results A total of 64 eyes (32 patients) were enrolled in the study. More eyes completed re-epithelialization in the TPRK group than in the Off-flap Epi-LASIK group 3–4 days postoperatively, while all eyes completed re-epithelialization by seven days. More eyes achieved a visual acuity (both UDVA and CDVA) of better than 20/20 in the TPRK group than in the Off-flap Epi-LASIK group. The ± 0.50 D predictability for correction of the spherical equivalent (SE) was higher in the eyes of the TPRK group (91%) than in those of the off-flap Epi-LASIK group (80%) 12 months after surgery. No significant differences in ocular aberrations, including coma, spherical, and trefoil, were found between the two groups at 12 months. There were also no significant differences in visual acuity, contrast sensitivity, pain, and haze grading between the two groups. Conclusions Both TPRK and off-flap Epi-LASIK are safe, effective, and predictable treatments for moderate to high myopia with comparable surgical outcomes. Trial registration: This study was retrospectively registered on ClinicalTrial.gov (NCT05060094, 17/09/2021).

Topographically Guided Two-Step LASIK and Standard LASIK in the Correction of Refractive Errors after Penetrating Keratoplasty

2009 ◽  
Vol 19 (4) ◽  
pp. 535-543 ◽  
Author(s):  
Leopoldo Spadea ◽  
Massimo Saviano ◽  
Angela Di Gregorio ◽  
Domenico Di Lodovico ◽  
Fabio De Sanctis
Keyword(s):  
Visual Acuity ◽  
Penetrating Keratoplasty ◽  
Laser In Situ Keratomileusis ◽  
Refractive Errors ◽  
Manifest Refraction ◽  
Uncorrected Visual Acuity ◽  
The Mean ◽  
Group 2 ◽  
Group 1

Purpose To evaluate in a long-term period the effectiveness and safety of topographically guided two-step laser in situ keratomileusis (LASIK) and standard LASIK technique in the correction of refractive errors after successful penetrating keratoplasty (PKP) for keratoconus. Methods At least 2 years after PKP and 6 months after removal of all sutures, 15 eyes of 15 patients (Group 1; mean manifest refraction spherical equivalent (MRSE) −7.23 D ± 3.42 SD) were submitted to standard LASIK and 15 eyes of 15 patients (Group 2; mean MRSE −4.37 D ± 1.97 SD) to a topographically guided two-step LASIK procedure (first the flap and at least 2 weeks later the laser ablation). In all cases, a superior hinged corneal flap (160 μm/9.5 mm) was created. Results After a follow-up of 36 months, in Group 1 the mean uncorrected visual acuity (UCVA) was 0.51 logarithm of the minimum angle of resolution (logMAR) ± 0.41 SD and the mean best-corrected visual acuity (BCVA) was 0.03 logMAR ± 0.05 SD, with a mean MRSE of −1.57 D ± 2.65 SD. In Group 2, the mean UCVA was 0.28 logMAR ± 0.24 SD and the mean BCVA was 0.01 logMAR ± 0.03 SD, with a mean MRSE of −0.07 D ± 1.00 SD. In both groups, no complications were observed. Conclusions After a long follow-up period, both topographically guided two-step LASIK and standard LASIK could be considered effective and safe tools in the correction of refractive errors after successful PKP for keratoconus.

scholarly journals Visual Outcomes of Adding Erythropoietin to Methylprednisolone for Treatment of Retrobulbar Optic Neuritis

2019 ◽  
Author(s):  
Mostafa Soltan Sanjari ◽  
Farzad Pakdel ◽  
Fatemeh Moosavi ◽  
Niloofar Pirmarzdashti ◽  
Marzieh Nojomi ◽  
...  
Keyword(s):  
Visual Acuity ◽  
Pilot Study ◽  
Optic Neuritis ◽  
Visual Outcome ◽  
Primary Outcome Measure ◽  
Recombinant Erythropoietin ◽  
Human Recombinant Erythropoietin ◽  
Retrobulbar Optic Neuritis ◽  
Group 2 ◽  
Group 1

Purpose: To compare the short-term visual function results and safety of erythropoietin as an add-on to the standard corticosteroid therapy in retrobulbar optic neuritis (RON). Methods: In this prospective pilot study, adult patients with isolated RON with less than 10 days of onset were enrolled. Patients were consecutively assigned to standard intravenous methylprednisolone treatment either in combination with intravenous erythropoietin (20,000 units/day for three days) (group-1) or alone (group-2). Primary outcome measure was best-corrected visual acuity (BCVA), which was assessed up to 120 days from the day the treatment was begun. Systemic evaluations were performed during and after treatment. Results: Sixty-two patients with RON (mean age = 26.6 ± 5.77 years; range = 18–40 years) were enrolled into the study (group-1, n = 35; group-2, n = 27). BCVA three months after the treatment was 0.19 ± 0.55 logMAR and 0.11 ± 0.32 logMAR in group-1 and group-2, respectively (95% CI: –0.61–0.16; P = 0.62). Change in BCVA after three months was 2.84 ± 3.49 logMAR in group-1 and 2.46 ± 1.40 logMAR in group-2 (95% CI: –0.93–1.91; P = 0.57). Pace of recovery was not significantly different between the groups. No complications were detected among patients. Conclusion: Intravenous erythropoietin as an add-on did not significantly improve the visual outcome in terms of visual acuity, visual field, and contrast sensitivity compared to traditional intravenous corticosteroid. This pilot study supports the safety profile of intravenous human recombinant erythropoietin, and it may help formulate future investigations with a larger sample size.

scholarly journals Testing the Medina embolization device in experimental aneurysms

2019 ◽  
Vol 131 (5) ◽  
pp. 1485-1493 ◽  
Author(s):  
Robert Fahed ◽  
Tim E. Darsaut ◽  
Igor Salazkin ◽  
Guylaine Gevry ◽  
Jean Raymond
Keyword(s):  
Flow Diverter ◽  
Group 3 ◽  
Group 2 ◽  
Aneurysmal Neck ◽  
Near Occlusion ◽  
Platinum Coils ◽  
Group 1

OBJECTIVEThe Medina embolization device (MED) is a novel, braided self-expanding endovascular device designed to occlude aneurysms by constructing an in situ intrasaccular flow diverter. Although a single device can be positioned at the neck of simple spherical in vitro aneurysms, the best way to occlude more complex in vivo aneurysms (using multiple MEDs or a combination of MEDs and platinum coils) is currently unknown.METHODSFifty-two aneurysms of 3 different types were created in 31 canines, yielding 48 patent aneurysms. Treatments were randomly allocated by drawing lots: group 1, MEDs alone (n = 16); group 2, MEDs plus standard platinum coils (n = 16); and group 3, control aneurysms treated with coils alone (n = 16). Angiographic results were scored and compared immediately following treatment completion and at 3 months. Specimens were photographed and the extent of neointimal closure of the aneurysmal neck scored, followed by histopathological analyses.RESULTSAngiographic scores of 0 or 1 (occlusion or near occlusion) were initially obtained in 2 of 16 (12.5%, 95% CI 1.6%–38.3%) group 1 (MEDs alone), 3 of 16 (18.7%, 95% CI 4%–45.6%) group 2 (MEDs plus coils), and 10 of 16 (62.5%, 95% CI 35.4%–84.8%) group 3 (coils alone) aneurysms (p = 0.005). At 3 months, scores of 0 or 1 were found in 11 of 16 (68.7%, 95% CI 41.3%–89.0%) group 1, 9 of 16 (56.2%, 95% CI 29.9%–80.2%) group 2, and 8 of 16 (50%, 95% CI 24.7%–75.3%) group 3 aneurysms (p = 0.82). Neointimal scores were similar for the 3 treated groups (p = 0.66).CONCLUSIONEndovascular treatment of experimental aneurysms with MEDs or MEDs and coils showed angiographic occlusion and neointimal scores at 3 months that were similar to those achieved with standard platinum coiling.

Visual Outcome in High Myopia After Laser in situ Keratomileusis

2000 ◽  
Vol 16 (2) ◽  
Author(s):  
Noel Moniz ◽  
Tony Fernandes ◽  
Kutty K Narayanan ◽  
Ani Sreedhar
Keyword(s):  
High Myopia ◽  
Visual Outcome ◽  
Laser In Situ Keratomileusis

scholarly journals Toxicity in Goats Exposed to Arsenic in the Region Lagunera, Northern Mexico

2020 ◽  
Vol 7 (2) ◽  
pp. 59
Author(s):  
Natalia B. Ortega-Morales ◽  
José A. Cueto-Wong ◽  
Eutiquio Barrientos-Juárez ◽  
Gonzalo García-Vargas ◽  
Homero Salinas-González ◽  
...  
Keyword(s):  
Rural Community ◽  
Physiological Condition ◽  
Arsenic Concentration ◽  
Ex Situ ◽  
Sampling Area ◽  
Group 4 ◽  
Group 3 ◽  
Group 2 ◽  
Group 1

The Region Lagunera, a region in northeast Mexico, is undergoing significant problems with the quality of its groundwater, which exceeds the permissible limits of contaminants and/or heavy metals stipulated in Mexican legislation. The present study evaluated chronic toxicity in male goats exposed to arsenic via one ex situ Group 1 (n = 5) and one in situ female goats Group 3 (n = 10). The treatment in Group 1 was carried out in the La Laguna experimental field of the Instituto Nacional de Investigaciones Forestales, Agrícolas y Pecuarias (INIFAP), located in Matamoros, Coahuila, Mexico. Sodium arsenite (2 mg/kg) was orally administered for 84 days to five male Creole goats, aged between four and five years old and weighing between 60 and 70 kg, in order to determine its effect on urine toxicity, libido, and physiological condition, an untreated group (n = 5) was included (Group 2). The experiment in group 3 was conducted on ten female Creole goats, aged between four and six years old and weighing between 40 and 49 kg, in both the contaminated sampling area in the rural community of El Venado and the control sampling area in the rural community of Nuevo Reynosa (Group 4 (n = 5)), in which the arsenic levels were measured in the urine of the exposed goats, as was their physiological condition. Significant differences (p < 0.01) between the groups were found in both the arsenic concentration in the urine and the physiological condition observed in both experimental groups.

scholarly journals Comparison of outcomes after topography-modified refraction versus wavefront-optimized versus manifest topography-guided LASIK

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Jaeryung Kim ◽  
Sung-Ho Choi ◽  
Dong Hui Lim ◽  
Gil-Joong Yoon ◽  
Tae-Young Chung
Keyword(s):  
Visual Acuity ◽  
Vector Analysis ◽  
Laser In Situ Keratomileusis ◽  
Distance Visual Acuity ◽  
Postoperative Astigmatism ◽  
Uncorrected Distance Visual Acuity ◽  
Manifest Refraction ◽  
Corrected Distance Visual Acuity ◽  
Myopic Astigmatism

Abstract Background To compare the outcomes of myopia and myopic astigmatism corrected with topography-modified refraction laser in situ keratomileusis (TMR-LASIK), wavefront-optimized (WFO) LASIK, and topography-guided (TG) LASIK with a correction target based on the manifest refraction (manifest TG-LASIK). Methods This observational, retrospective cohort study included patients who underwent LASIK using the WaveLight® EX500 excimer laser to correct myopia and myopic astigmatism between August 2016 and July 2017. Patients who underwent TMR-LASIK (85 patients), WFO-LASIK (70 patients), or manifest TG-LASIK (40 patients) were enrolled, and only one eye from each patient was analyzed. All participants underwent measurement of the uncorrected distance visual acuity (UDVA), best-corrected distance visual acuity (BCVA), manifest refraction, vector analysis of astigmatic change, corneal topography, and corneal wavefront analysis at baseline and at every posttreatment visit. Results Three months postoperatively, a UDVA of 0.0 logMAR or better and manifest refraction spherical equivalent (MRSE) within ±0.5 diopters (D) did not differ across the TMR-, WFO-, and manifest TG-LASIK groups. However, the residual cylinder in the TMR group was significantly larger than that in the WFO and manifest TG groups. The magnitude of error in the TMR group measured using astigmatism vector analysis was significantly higher than that in the WFO and manifest TG groups. Conclusions Although these three LASIK platforms achieved the predicted surgical outcomes, TMR-LASIK overcorrected astigmatism and showed a higher residual postoperative astigmatism compared with WFO- and manifest TG-LASIK.

scholarly journals Immediate and mid-term effects of elastic taping on gymnast’s postural control performance during a handstand

2015 ◽  
Vol 7 (4) ◽  
pp. 73-84
Author(s):  
PIA M. VINKEN ◽  
THOMAS HEINEN
Keyword(s):  
Postural Control ◽  
Center Of Pressure ◽  
Sensory Stimulation ◽  
Control Performance ◽  
Forearm Muscles ◽  
Group 3 ◽  
Group 2 ◽  
Wrist Joints ◽  
Group 1

Background: The study explored whether three different applications of an elastic tape on the forearms of healthy, active gymnasts influence their postural control performance during a handstand immediately and 48 hours after application. Material/Methods: 24 gymnasts were randomly assigned to three groups: group 1 – elastic tape application at a gymnast’s wrist joints, group 2 – elastic tape application at a gymnast’s forearm muscles, and group 3 – a combination of groups 1 and 2. The gymnast’s center of pressure was measured with a mobile balance platform, indicating postural control performance during a handstand. Results: The gymnast’s postural control performance during a handstand is affected depending on the elastic tape application and the time span the application is in situ. Elastic tape application on a gymnast’s wrist joints reveals a performance increase immediately and 48 hours after application. Elastic tape application on a gymnast’s forearm muscles increases performance when applied for 48 hours. Combined elastic tape application does not additionally affect gymnast’s postural control performance. Conclusions: Elastic tape applications can increase postural control performance during a handstand. Furthermore, it is supposed that mechano-sensory stimulation, improved attention and awareness due to elastic tape application and the belief in its effectiveness may be moderating mechanisms of this effect.

scholarly journals HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials

2016 ◽  
Vol 34 (29) ◽  
pp. 3518-3528 ◽  
Author(s):  
Michael F. Press ◽  
Guido Sauter ◽  
Marc Buyse ◽  
Hélène Fourmanoir ◽  
Emmanuel Quinaux ◽  
...  
Keyword(s):  
In Situ Hybridization ◽  
Breast Cancers ◽  
Her2 Gene ◽  
Group 4 ◽  
International Research Group ◽  
Group 3 ◽  
Group 5 ◽  
Group 2 ◽  
Group 1

Purpose ASCO and the College of American Pathologists (ASCO-CAP) recently recommended further changes to the evaluation of human epidermal growth factor receptor 2 gene (HER2) amplification by fluorescent in situ hybridization (FISH). We retrospectively assessed the impact of these new guidelines by using annotated Breast Cancer International Research Group (BCIRG) -005, BCIRG-006, and BCIRG-007 clinical trials data for which we have detailed outcomes. Patients and Methods The HER2 FISH status of BCIRG-005/006/007 patients with breast cancers was re-evaluated according to current ASCO-CAP guidelines, which designates five different groups according to HER2 FISH ratio and average HER2 gene copy number per tumor cell: group 1 (in situ hybridization [ISH]–positive): HER2-to-chromosome 17 centromere ratio ≥ 2.0, average HER2 copies ≥ 4.0; group 2 (ISH-positive): ratio ≥ 2.0, copies < 4.0; group 3 (ISH-positive): ratio < 2.0, copies ≥ 6.0; group 4 (ISH-equivocal): ratio < 2.0, copies ≥ 4.0 and < 6.0; and group 5 (ISH-negative): ratio < 2.0, copies < 4.0. We assessed correlations with HER2 protein, clinical outcomes by disease-free survival (DFS) and overall survival (OS) and benefit from trastuzumab therapy (hazard ratio [HR]). Results Among 10,468 patients with breast cancers who were successfully screened for trial entry, 40.8% were in ASCO-CAP ISH group 1, 0.7% in group 2; 0.5% in group 3, 4.1% in group 4, and 53.9% in group 5. Distributions were similar in screened compared with accrued subpopulations. Among accrued patients, FISH group 1 breast cancers were strongly correlated with immunohistochemistry 3+ status (P < .0001), whereas groups 2, 3, 4, and 5 were not; however, groups 2, 4 and, 5 were strongly correlated with immunohistochemistry 0/1+ status (all P < .0001), whereas group 3 was not. Among patients accrued to BCIRG-005, group 4 was not associated with significantly worse DFS or OS compared with group 5. Among patients accrued to BCIRG-006, only group 1 showed a significant benefit from trastuzumab therapy (DFS HR, 0.71; 95% CI, 0.60 to 0.83; P < .0001; OS HR, 0.69; 95% CI, 0.55 to 0.85; P = .0006), whereas group 2 did not. Conclusion Our findings support the original categorizations of HER2 by FISH status in BCIRG/Translational Research in Oncology trials.

Sign in / Sign up

Export Citation Format

Share Document